Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a sale of 11,962 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total market value of $80,025.78. Following the sale, Secora Michael directly holds 1,353,381 shares in the company. The sale was reported as a means to cover the payment of exercise price or tax liability by delivering or withholding securities.

Recursion Pharmaceuticals' Chief Financial Officer, Secora Michael, completed a sale of 11,962 shares of the company's Class A Common Stock on August 15, 2024. The transaction was carried out at a price of $6.69 per share, resulting in a total market value of $80,025.78. Following the sale, Secora Michael directly holds 1,353,381 shares in the company. The sale was reported as a means to cover the payment of exercise price or tax liability by delivering or withholding securities.